These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20953959)

  • 1. Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction.
    Miettinen JA; Ylitalo K; Hedberg P; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
    Clin Res Cardiol; 2011 Apr; 100(4):317-25. PubMed ID: 20953959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy.
    Miettinen JA; Ylitalo K; Hedberg P; Jokelainen J; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
    Heart; 2010 Mar; 96(5):362-7. PubMed ID: 19910293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry.
    Luu B; Leistner DM; Herrmann E; Seeger FH; Honold J; Fichtlscherer S; Zeiher AM; Assmus B
    Circ Res; 2017 Jun; 120(12):1938-1946. PubMed ID: 28351842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
    van Diepen S; Roe MT; Lopes RD; Stebbins A; James S; Newby LK; Moliterno DJ; Neumann FJ; Ezekowitz JA; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Theroux P; Granger CB
    J Thromb Thrombolysis; 2012 Jul; 34(1):106-13. PubMed ID: 22307842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: quantum of initial necrosis is the key.
    Obradović S; Balint B; Romanovic R; Trifunović Z; Rusović S; Baskot B; Dopudja M; Trifunović G; Rafajlovski S; Jung R; Gligić B
    Vojnosanit Pregl; 2009 Dec; 66(12):998-1004. PubMed ID: 20095521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intracoronary autologous mononuclear bone marrow cell transplantation on cardiac arrhythmia and heart rate variability.
    Trzos E; Krzemińska-Pakuła M; Rechciński T; Plewka M; Kasprzak J; Peruga JZ; Korycka A; Wierzbowska A; Kurpesa M
    Kardiol Pol; 2009 Jul; 67(7):713-21. PubMed ID: 19649993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.
    Huikuri HV; Kervinen K; Niemelä M; Ylitalo K; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen JK; Knuuti J; Mäkikallio TH;
    Eur Heart J; 2008 Nov; 29(22):2723-32. PubMed ID: 18845667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
    Seitz A; Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; May AE; Empen K; Chorianopoulos E; Ritter B; Pirr J; Arseniev L; Heuft HG; Ganser A; Abu-Zaid E; Katus HA; Felix SB; Gawaz MP; Schultheiss HP; Ladage D; Bauersachs J; Mahrholdt H; Greulich S
    Clin Res Cardiol; 2020 May; 109(5):539-548. PubMed ID: 31401672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the change in brain natriuretic peptide after ST-elevation myocardial infarction (STEMI): why should it be better than baseline?
    Ezekowitz JA; Théroux P; Welsh R; Bata I; Webb J; Armstrong PW
    Can J Physiol Pharmacol; 2007 Jan; 85(1):173-8. PubMed ID: 17487257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
    Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Hölschermann H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Assmus B; Tonn T; Dimmeler S; Zeiher AM;
    N Engl J Med; 2006 Sep; 355(12):1210-21. PubMed ID: 16990384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study.
    Huang R; Yao K; Sun A; Qian J; Ge L; Zhang Y; Niu Y; Wang K; Zou Y; Ge J
    Stem Cell Res Ther; 2015 May; 6(1):112. PubMed ID: 26021558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; Bonarjee V; Larsen AI; May AE; Empen K; Chorianopoulos E; Tebbe U; Waltenberger J; Mahrholdt H; Ritter B; Pirr J; Fischer D; Korf-Klingebiel M; Arseniev L; Heuft HG; Brinchmann JE; Messinger D; Hertenstein B; Ganser A; Katus HA; Felix SB; Gawaz MP; Dickstein K; Schultheiss HP; Ladage D; Greulich S; Bauersachs J
    Eur Heart J; 2017 Oct; 38(39):2936-2943. PubMed ID: 28431003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI.
    Quyyumi AA; Vasquez A; Kereiakes DJ; Klapholz M; Schaer GL; Abdel-Latif A; Frohwein S; Henry TD; Schatz RA; Dib N; Toma C; Davidson CJ; Barsness GW; Shavelle DM; Cohen M; Poole J; Moss T; Hyde P; Kanakaraj AM; Druker V; Chung A; Junge C; Preti RA; Smith RL; Mazzo DJ; Pecora A; Losordo DW
    Circ Res; 2017 Jan; 120(2):324-331. PubMed ID: 27821724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcoronary transplantation of progenitor cells after myocardial infarction.
    Assmus B; Honold J; Schächinger V; Britten MB; Fischer-Rasokat U; Lehmann R; Teupe C; Pistorius K; Martin H; Abolmaali ND; Tonn T; Dimmeler S; Zeiher AM
    N Engl J Med; 2006 Sep; 355(12):1222-32. PubMed ID: 16990385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†.
    Choudry F; Hamshere S; Saunders N; Veerapen J; Bavnbek K; Knight C; Pellerin D; Locca D; Westwood M; Rakhit R; Crake T; Kastrup J; Parmar M; Agrawal S; Jones D; Martin J; Mathur A
    Eur Heart J; 2016 Jan; 37(3):256-63. PubMed ID: 26405233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.